摘要
目的:掌握遂昌县农村妇女宫颈癌和乳腺癌(简称"两癌")的发病率,早期发现、早期治疗,降低"两癌"的治疗成本,提高患病妇女的生存率。方法:对2009年自愿参加"两癌"免费筛查的24 099例农村妇女的资料进行统计分析。结果:24 099例妇女中,宫颈细胞学异常578例,经组织活检确诊为宫颈癌18例,患病率为74.69/10万(18/24 099);宫颈上皮内瘤变(CIN)110例,患病率为456.45/10万(110/24 099);乳腺癌2例,患病率为8.3/10万(2/24 099)。宫颈癌多见于40~64岁妇女,乳腺癌多见于50~55岁妇女。结婚和生育年龄较早是宫颈癌的高危因素;文化程度低、保健意识不强、经济条件差的农村妇女是"两癌"的高发人群,也是重点干预对象。结论:农村妇女"两癌"发病率高,应加大农村防癌普查力度,希望政府能继续执行惠民政策,切实做到早预防、早发现和早治疗。
Objective: To grasp the incidences of cervical cancer and breast cancer ("two cancer" for short) among the rural women in Suichang county, in order to diagnose and cure early, reduce the treatment cost, and increase the survival rate of ill women. Methods: The data of 24 099 rural women who underwent free " two cancer" screening voluntarily in 2009 were analyzed statistically. Results: Among 24 099 women, 578 women were found with abnormal cervical cytological results, 18 women were diagnosed as cervical cancer definitely by biopsy, the prevalence was 74. 69/100 000 (18/24 099) ; 110 women were found with cervical intraepithelial neoplasia (CIN), the prevalence was 456. 45/100 000 (110/24 099 ) ; two women were found with breast cancer, the prevalence was 8.3/ 100 000 (2/24 099) . Cervical cancer was commonly found in 40 -64 - year - old women, while breast cancer was commonly found in 50 -55 -yearold women. Marriage and young childbearing age were high risk factors of cervical cancer; the rural women with low educational level, weak health consciousness, and poor economic condition were high - risk population of "two cancer" and key intervention objects. Conclusion: The incidences of "two cancer" among the rural women in Suichang county were high; prevention and general investiga- tion of cancer should be enhanced among the rural women, it is expected that the government can continue people - benefit project and ensure early prevention, early diagnosis, and early treatment.
出处
《中国妇幼保健》
CAS
北大核心
2012年第16期2427-2429,共3页
Maternal and Child Health Care of China
关键词
农村妇女
宫颈癌
乳腺癌
筛查
患病率
预防
Rural women
Cervical cancer
Breast cancer
Screening
Prevalence rate
Prevention